Introduction
proteinuria increased slightly to more than 1 g/day, indicating progressive diabetic nephropathy [5] . Diabetic nephropathy is one of the major causes of Proteinuria further increased during the following end stage renal disease ( ESRD). In patients with months, despite ACE-inhibitor medication ( Figure 1 ). ESRD due to diabetic nephropathy, the incidence of However, renal function remained stable until July typical diabetic lesions in the renal allograft is nearly 1997, when the patient was admitted to our clinic with 100% at 2 years after transplantation [1] . The incidence a rise in serum creatinine from 120 to 190 mmol/l of de novo diabetic nephropathy in previously non- ( Figure 1 ). Current medication consisted of azathiodiabetic renal allograft recipients varies between 2 and prine (50 mg/day), methylprednisolone (16 mg/day), 5% [2-4]. Here we report an unusual case of steroid-digitoxin (0.07 mg/day), furosemide (20 mg/day), induced diabetic nephropathy in a renal allograft minoxidil (0.2 mg/day), fosinopril (10 mg/day), and a recipient, which resulted in ESRD and resumption combination of long-acting insulin (28 IU/day) and of haemodialysis 29 years after allogenic renal short acting insulin (30 IU/day). Physical examination transplantation.
revealed high blood pressure (180/100 mmHg), bilateral ankle oedema, a systolic murmur over the apex, and signs of early peripheral diabetic polyneuropathy.
Case
Urinalysis was positive for glucose and protein (5.5 g/day). Ultrasound examination showed a normal-A 62-year-old Caucasian woman with ESRD due to sized graft with moderately increased echodensity of recurrent bacterial tubulointerstitial nephritis (no the parenchyma. Duplex ultrasound revealed normal biopsy performed ) had received a cadaveric renal resistance indices (RI 0.75). Laboratory findings were allograft in 1968. In addition, there was a history of normal except for elevations in serum creatinine hypertension and pre-eclampsia during her third (202 mmol/l ), urea (20.6 mmol/l ) and cGT (2.1 pregnancy of five. Throughout 29 years, she had stable mmol/l ). There was no evidence for acute infection. graft function with serum creatinine levels ranging Without a biopsy, she was empirically treated with between 80 and 100 mmol/l. Mild hypertension was steroid pulse therapy (250 mg methylprednisolone/day, treated with diuretics and/or calcium antagonists. i.v., for 3 days). Thereafter, serum creatinine levels Chronic hepatitis C was first documented in 1968. Ten remained elevated around 200 mmol/l and she was years ago, hyperglycaemia was noted for the first time discharged. (fasting glucose levels >140 mg/dl, 1 h postprandial Two weeks later the patient presented with further C-peptide level 20 ng/ml ). This was regarded as a side-deterioration of renal function (rise of serum creatinine effect of maintenance immunosuppression, which con-from 200 to 260 mmol/l ) and was hospitalized again. sisted of prednisolone (15-20 mg/day) and azathio-A core biopsy of the renal allograft was performed prine (25-75 mg/day). From 1988 until 1991, the which revealed no signs of rejection, but clear evidence for diabetic nephropathy ( Figure 2 ). During the Correspondence and offprint requests to: Dr med. Johannes Waiser, following weeks, renal function declined continuously and the patient developed symptoms of uraemia. As renal function did not recover, she finally returned to regular maintenance haemodialysis, 29 years after allogenic renal transplantation.
Discussion
In diabetic patients, microalbuminuria develops within 10-15 years of the onset of hyperglycaemia and progresses to proteinuria (>0.15 g/day) within the following 3-7 years. The time interval between the onset of proteinuria and a detectable decline in GFR is quite variable. Usually the average duration of this period is 5-7 years. In most patients, hypertension also supervenes and is a marker of disease progression. In primarily diabetic renal allograft recipients, histo- expansion. About 4 years after transplantation, hyalinization of afferent and efferent arterioles occur [7] . There are no sufficient data concerning the time interval between the onset of diabetes mellitus and the onset from hyperglycaemia to ESRD was quicker compared to other patients [8] . As there were no signs for of overt proteinuria (>1 g/day). According to the literature, progression from overt proteinuria to ESRD rejection throughout 29 years, non-immunological cofactors may have accelerated the course of diabetic takes several years [8] . Therefore graft loss due to diabetic nephropathy usually occurs in the second nephropathy in this patient. The fast progression of diabetic nephropathy indicates that the longevity of decade after transplantation [9] . The incidence of de novo diabetes mellitus after renal transplantation aver-renal allografts may be particularly susceptible to the harmful effects of diabetes mellitus. ages around 2.5% [10] . It was suggested that the number of steroid pulse courses might be a crucial Histopathology showed focal segmental nodular glomerulosclerosis and mild mesangial thickening, factor for the onset of post-transplant diabetes mellitus [9] . However, some investigators could not detect a arteriolosclerosis and atherosclerosis, interstitial fibrosis, and mild lymphocyte infiltration. There was significant correlation between the occurrence of posttransplant diabetes mellitus and the cumulative dose no evidence of chronic rejection (absence of tubulitis, endovasculitis, endothelial cell enlargement, and of steroids or the type of immunosuppression employed [10] .
reduplication of the basement membranes; only mild interstitial lymphocyte infiltration; negative immunoIn the patient described here, the onset of posttransplant diabetes mellitus was nearly 20 years after fluorescence with IgG, IgM and C3), amyloidosis (negative Congo-red staining), light-chain nephropathy renal transplantation. To our knowledge, such a late manifestation of post-transplant diabetes mellitus has (negative immunofluorescence staining with kappa and lambda light-chains) and membranoproliferative not been described previously. The time interval between the detection of hyperglycaemia (1988) and glomerulonephritis (no mesangial hypercellularity; no peripheral reduplication of glomerular basement memthe onset of proteinuria (1991) was unusually short and the progression from overt proteinuria to ESRD branes; negative immunofluorescence staining with IgG, IgM, IgA, C3, C4, C1q). All these conditions are was unusually fast (9 months). Therefore, progression
